Showing 6 of 6 Jobs
Chennai, Tamil Nadu, India
Chennai, Tamil Nadu, India
Hamburg, Germany
Gaithersburg, MD, USA
Cambridge, UK
Full-Time
Develops and commercializes prescription medicines
No salary listed
Senior
Chennai, Tamil Nadu, India
Minimum of three days per week in the office.
Upload your resume to see how it matches 21 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and forming strategic partnerships, such as their Open Innovation program, which allows collaboration with the scientific community to speed up drug discovery. The company's goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through innovation and collaboration.
Company Size
10,001+
Company Stage
IPO
Headquarters
Cambridge, United Kingdom
Founded
1913
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Flexible Work Hours
Enhertu combination improved PFS in 1L HER2+ mBC
AstraZeneca unit faces class-action suit over alleged soliris monopoly.
In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.
11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast
Simplify Jobs | Apply to Jobs